Pro-Inflammatory and Anti-Inflammatory Cytokines Levels are Significantly Altered in Cerebrospinal Fluid of Unruptured Intracranial Aneurysm (UIA) Patients

References

• Aoki T, Nishimura M, Matsuoka T, et al. PGE 2-EP 2 signalling in endothelium is activated by haemodynamic stress and induces cerebral aneurysm through an amplifying loop via NF-κB. Br J Pharmacol. 2011;163(6):1237–1249. doi:10.1111/j.1476-5381.2011.01358.x
   PubMed Web of Science ®Google Scholar
• Hashimoto T, Meng H, Young WL. Intracranial aneurysms: links among inflammation, hemodynamics and vascular remodeling. Neurol Res. 2006;28(4):372–380. doi:10.1179/016164106X14973
   PubMed Web of Science ®Google Scholar
• Chalouhi N, Ali MS, Jabbour PM, et al. Biology of intracranial aneurysms: role of inflammation. J Cereb Blood Flow Metab. 2012;32(9):1659–1676. doi:10.1038/jcbfm.2012.84
   PubMed Web of Science ®Google Scholar
• Kamińska J, Lyson T, Chrzanowski R, et al. Ratio of IL-8 in CSF versus serum is elevated in patients with unruptured brain aneurysm. J Clin Med. 2020;9(6):1761. doi:10.3390/jcm9061761
   PubMed Web of Science ®Google Scholar
• Kamińska J, Dymicka-Piekarska V, Chrzanowski R, et al. Il-6 quotient (the ratio of cerebrospinal fluid il-6 to serum il-6) as a biomarker of an unruptured intracranial aneurysm. J Inflamm Res. 2021;14:6103–6114. doi:10.2147/JIR.S335618
   PubMed Web of Science ®Google Scholar
• Yang S, Liu Q, Yang J, Wu J, Wang S. Increased levels of serum IL-15 and TNF-β indicate the progression of human intracranial aneurysm. Front Aging Neurosci. 2022;14. doi:10.3389/fnagi.2022.903619
   Web of Science ®Google Scholar
• Liu Q, Zhang Y, Yang J, et al. The relationship of morphological-hemodynamic characteristics, inflammation, and remodeling of aneurysm wall in unruptured intracranial aneurysms. Transl Stroke Res. 2022;13(1):88–99. doi:10.1007/s12975-021-00917-1
   PubMed Web of Science ®Google Scholar
• Frösen J, Cebral J, Robertson AM, Aoki T. Flow-induced, inflammation-mediated arterial wall remodeling in the formation and progression of intracranial aneurysms. Neurosurg Focus. 2019;47(1):E21. doi:10.3171/2019.5.FOCUS19234
   PubMed Web of Science ®Google Scholar
• Chen Z, Song S, Zhu J, Lai X. Regulatory mechanism of MiR-21 in formation and rupture of intracranial aneurysm through JNK signaling pathway-mediated inflammatory response. Int J Clin Exp Pathol. 2020;13(7):1834–1841.
   PubMed Web of Science ®Google Scholar
• Zhang H-F, Zhao M-G, Liang G-B, Song Z-Q, Li Z-Q. Expression of pro-inflammatory cytokines and the risk of intracranial aneurysm. Inflammation. 2013;36(6):1195–1200. doi:10.1007/s10753-013-9655-6
   PubMed Web of Science ®Google Scholar
• Aoki T, Kataoka H, Shimamura M, et al. NF-κB is a key mediator of cerebral aneurysm formation. Circulation. 2007;116(24):2830–2840. doi:10.1161/CIRCULATIONAHA.107.728303
   PubMed Web of Science ®Google Scholar
• Chalouhi N, Points L, Pierce GL, Ballas Z, Jabbour P, Hasan D. Localized increase of chemokines in the lumen of human cerebral aneurysms. Stroke. 2013;44(9):2594–2597. doi:10.1161/STROKEAHA.113.002361
   PubMed Web of Science ®Google Scholar
• Aoki T, Fukuda M, Nishimura M, Nozaki K, Narumiya S. Critical role of TNF-alpha-TNFR1 signaling in intracranial aneurysm formation. Acta Neuropathol Commun. 2014;2(1):34. doi:10.1186/2051-5960-2-34
   PubMed Web of Science ®Google Scholar
• Yi C, Katina W, He G, et al. Myeloperoxidase is increased in human cerebral aneurysms and increases formation and rupture of cerebral aneurysms in mice. Stroke. 2015;46(6):1651–1656. doi:10.1161/STROKEAHA.114.008589.Myeloperoxidase
   PubMed Web of Science ®Google Scholar
• Cheng WT, Wang N. Correlation between MMP-2 and NF-κ B expression of intracranial aneurysm. Asian Pac J Trop Med. 2013;6(7):570–573. doi:10.1016/S1995-7645(13)60098-X
   PubMed Web of Science ®Google Scholar
• Aoki T, Kataoka H, Ishibashi R, Nozaki K, Egashira K, Hashimoto N. Impact of monocyte chemoattractant protein-1 deficiency on cerebral aneurysm formation. Stroke. 2009;40(3):942–951. doi:10.1161/STROKEAHA.108.532556
   PubMed Web of Science ®Google Scholar
• Hosaka K, Hoh BL. Inflammation and cerebral aneurysms. Transl Stroke Res. 2014;5(2):190–198. doi:10.1007/s12975-013-0313-y
   PubMed Web of Science ®Google Scholar
• Nowicki KW, Hosaka K, He Y, McFetridge PS, Scott EW, Hoh BL. Novel high-throughput in vitro model for identifying hemodynamic-induced inflammatory mediators of cerebral aneurysm formation. Hypertension. 2014;64(6):1306–1313. doi:10.1161/HYPERTENSIONAHA.114.03775
   PubMed Web of Science ®Google Scholar
• Nowicki KW, Hosaka K, Walch FJ, Scott EW, Hoh BL. M1 macrophages are required for murine cerebral aneurysm formation. J Neurointerv Surg. 2018;10(1):93–97. doi:10.1136/neurintsurg-2016-012911
   PubMed Web of Science ®Google Scholar
• Kosierkiewicz TA, Factor SM, Dickson DW. Immunocytochemical studies of atherosclerotic lesions of cerebral berry aneurysms. J Neuropathol Exp Neurol. 1994;53(4):399–406. doi:10.1097/00005072-199407000-00012
   PubMed Web of Science ®Google Scholar
• Kanematsu Y, Kanematsu M, Kurihara C, et al. Critical roles of macrophages in the formation of intracranial aneurysm. Stroke. 2011;42(1):173–178. doi:10.1161/STROKEAHA.110.590976
   PubMed Web of Science ®Google Scholar
• Starke R, Chalouhi N, Ali M, et al. The role of oxidative stress in cerebral aneurysm formation and rupture. Curr Neurovasc Res. 2013;10(3):247–255. doi:10.2174/15672026113109990003
   PubMed Web of Science ®Google Scholar
• Jayaraman T. TNF-α-mediated inflammation in cerebral aneurysms: a potential link to growth and rupture. Vasc Health Risk Manag. 2008;4(24):805–817. doi:10.2147/VHRM.S2700
   PubMedGoogle Scholar
• Fukuda S, Hashimoto N, Naritomi H, et al. Prevention of rat cerebral aneurysm formation by inhibition of nitric oxide synthase. Circulation. 2000;101(21):2532–2538. doi:10.1161/01.CIR.101.21.2532
   PubMed Web of Science ®Google Scholar
• Pentimalli L, Modesti A, Vignati A, et al. Role of apoptosis in intracranial aneurysm rupture. J Neurosurg. 2004;101(6):1018–1025. doi:10.3171/jns.2004.101.6.1018
   PubMed Web of Science ®Google Scholar
• Oka M, Shimo S, Ohno N, et al. Dedifferentiation of smooth muscle cells in intracranial aneurysms and its potential contribution to the pathogenesis. Sci Rep. 2020;10(1):1–5. doi:10.1038/s41598-020-65361-x
   PubMed Web of Science ®Google Scholar
• Ducruet AF. Commentary on’Inflammatory changes in the aneurysm wall: a review’. J Neurointerv Surg. 2018;10(Suppl 1):i56–i56. doi:10.1136/neurintsurg-2018-014090
   PubMed Web of Science ®Google Scholar
• Tawk RG, Hasan TF, D’Souza CE, Peel JB, Freeman WD. Diagnosis and treatment of unruptured intracranial aneurysms and aneurysmal subarachnoid hemorrhage. Mayo Clin Proc. 2021;96(7):1970–2000. doi:10.1016/j.mayocp.2021.01.005
   PubMed Web of Science ®Google Scholar
• Koper-Lenkiewicz OM, Sutkowska K, Wawrusiewicz-Kurylonek N, Kowalewska E, Matowicka-Karna J. Proinflammatory cytokines (IL-1, −6, −8, −15, −17, −18, −23, TNF-α) single nucleotide polymorphisms in rheumatoid arthritis—a literature review. Int J Mol Sci. 2022;23(4):2106. doi:10.3390/ijms23042106
   PubMed Web of Science ®Google Scholar
• Zhang J-M, An J. Cytokines, inflammation, and pain. Int Anesthesiol Clin. 2007;45(2):27–37. doi:10.1097/AIA.0b013e318034194e
   PubMedGoogle Scholar
• Capobianco MP, Cassiano GC, da Cruz Furini AA, Storti de Melo LM, Bonini Domingos CR, Dantas Machado RL. Human interleukin 2 (IL-2) promotion of immune regulation and clinical outcomes: a review. J Cytokine Biol. 2016;01(02):14–17. doi:10.4172/2576-3881.1000109
   Google Scholar
• Dougan M, Dranoff G, Dougan SK. GM-CSF, IL-3, and IL-5 family of cytokines: regulators of inflammation. Immunity. 2019;50(4):796–811. doi:10.1016/j.immuni.2019.03.022
   PubMed Web of Science ®Google Scholar
• Hartgring SAY, Willis CR, Bijlsma JWJ, Lafeber FPJG, van Roon JAG. Interleukin-7-aggravated joint inflammation and tissue destruction in collagen-induced arthritis is associated with T-cell and B-cell activation. Arthritis Res Ther. 2012;14(3):R137. doi:10.1186/ar3870
   PubMed Web of Science ®Google Scholar
• Aldinucci D, Colombatti A. The inflammatory chemokine CCL5 and cancer progression. Mediators Inflamm. 2014;2014:1–12. doi:10.1155/2014/292376
   Web of Science ®Google Scholar
• Mello JDC, Gomes LEM, Silva JF, et al. The role of chemokines and adipokines as biomarkers of Crohn’s disease activity: a systematic review of the literature. Am J Transl Res. 2021;13(8):8561–8574.
   PubMed Web of Science ®Google Scholar
• Serna-Rodríguez MF, Bernal-Vega S, de la Barquera JAO-S, Camacho-Morales A, Pérez-Maya AA. The role of damage associated molecular pattern molecules (DAMPs) and permeability of the blood-brain barrier in depression and neuroinflammation. J Neuroimmunol. 2022;371:577951. doi:10.1016/j.jneuroim.2022.577951
   PubMed Web of Science ®Google Scholar
• Cuneo A, Autieri M. Expression and function of anti-inflammatory interleukins: the other side of the vascular response to injury. Curr Vasc Pharmacol. 2009;7(3):267–276. doi:10.2174/157016109788340721
   PubMed Web of Science ®Google Scholar
• Kao HW, Lee KW, Kuo CL, et al. Interleukin-6 as a prognostic biomarker in ruptured intracranial aneurysms. PLoS One. 2015;10(7):6–13. doi:10.1371/journal.pone.0132115
   Web of Science ®Google Scholar
• Hendryk S, Jarzab B, Josko J. Increase of the IL-1 beta and IL-6 levels in CSF in patients with vasospasm following aneurysmal SAH. Neuro Endocrinol Lett. 2004;25(1–2):141–147.
   PubMed Web of Science ®Google Scholar
• Moriwaki T, Takagi Y, Sadamasa N, Aoki T, Nozaki K, Hashimoto N. Impaired progression of cerebral aneurysms in interleukin-1β-deficient mice. Stroke. 2006;37(3):900–905. doi:10.1161/01.STR.0000204028.39783.d9
   PubMed Web of Science ®Google Scholar
• Aoki T, Yamamoto K, Fukuda M, Shimogonya Y, Fukuda S, Narumiya S. Sustained expression of MCP-1 by low wall shear stress loading concomitant with turbulent flow on endothelial cells of intracranial aneurysm. Acta Neuropathol Commun. 2016;4(1):48. doi:10.1186/s40478-016-0318-3
   PubMed Web of Science ®Google Scholar
• Signorelli F, Sela S, Gesualdo L, et al. Hemodynamic stress, inflammation, and intracranial aneurysm development and rupture: a systematic review. World Neurosurg. 2018;115:234–244. doi:10.1016/j.wneu.2018.04.143
   PubMed Web of Science ®Google Scholar
• Signorelli F, Turjman F, Gory B, Labeyrie P-E, Pelissou-Guyotat I, Riva R. Hemodynamics, inflammation, vascular remodeling, and the development and rupture of intracranial aneurysms: a review. Neuroimmunol Neuroinflamm. 2015;2(2):59. doi:10.4103/2347-8659.154885
   Google Scholar
• Signorelli F, Pailler-Mattei C, Gory B, et al. Biomechanical characterization of intracranial aneurysm wall: a multiscale study. World Neurosurg. 2018;119:e882–e889. doi:10.1016/j.wneu.2018.07.290
   PubMed Web of Science ®Google Scholar
• Koper OM, Kamińska J, Grygorczuk S, Zajkowska J, Kemona H. CXCL9 concentrations in cerebrospinal fluid and serum of patients with tick-borne encephalitis. Arch Med Sci. 2018;14(2):313–320. doi:10.5114/aoms.2016.58667
   PubMed Web of Science ®Google Scholar
• Koper-Lenkiewicz OM, Kamińska J, Milewska A, et al. Serum and cerebrospinal fluid Neudesin concentration and Neudesin quotient as potential circulating biomarkers of a primary brain tumor. BMC Cancer. 2019;19(1):319. doi:10.1186/s12885-019-5525-4
   PubMed Web of Science ®Google Scholar
• Koper OM, Kamińska J, Sawicki K, et al. Cerebrospinal fluid and serum IL-8, CCL2, and ICAM-1 concentrations in astrocytic brain tumor patients. Ir J Med Sci. 2018;187(3):767–775. doi:10.1007/s11845-017-1695-8
   PubMed Web of Science ®Google Scholar
• Cao Y, Zhao J, Wang S, Zhong H, Wu B. Monocyte chemoattractant protein-1 mRNA in human intracranial aneurysm walls. Zhonghua Yu Fang Yi Xue Za Zhi. 2002;36(7):519–521. doi:10.1136/jnnp-2011-302068
   PubMed Web of Science ®Google Scholar
• Hansson GK, Libby P. The immune response in atherosclerosis: a double-edged sword. Nat Rev Immunol. 2006;6(7):508–519. doi:10.1038/nri1882
   PubMed Web of Science ®Google Scholar
• Labeyrie P-E, Goulay R, Martinez de Lizarrondo S, et al. Vascular tissue-type plasminogen activator promotes intracranial aneurysm formation. Stroke. 2017;48(9):2574–2582. doi:10.1161/STROKEAHA.117.017305
   PubMed Web of Science ®Google Scholar
• Zhang H-F, Zhao M-G, Liang G-B, et al. Dysregulation of CD4 + T cell subsets in intracranial aneurysm. DNA Cell Biol. 2016;35(2):96–103. doi:10.1089/dna.2015.3105
   PubMed Web of Science ®Google Scholar
• Dymicka-Piekarska V, Koper-Lenkiewicz OM, Zińczuk J, Kratz E, Kamińska J. Inflammatory cell-associated tumors. Not only macrophages (TAMs), fibroblasts (TAFs) and neutrophils (TANs) can infiltrate the tumor microenvironment. The unique role of tumor associated platelets (TAPs). Cancer Immunol Immunother. 2020;70:1497–1510. doi:10.1007/s00262-020-02758-7
   PubMed Web of Science ®Google Scholar
• Miyata H, Koseki H, Takizawa K, et al. T cell function is dispensable for intracranial aneurysm formation and progression. PLoS One. 2017;12(4):1–13. doi:10.1371/journal.pone.0175421
   Web of Science ®Google Scholar
• Sawyer DM, Amenta PS, Medel R, Dumont AS. Inflammatory mediators in vascular disease: identifying promising targets for intracranial aneurysm research. Mediators Inflamm. 2015;2015:1–10. doi:10.1155/2015/896283
   Web of Science ®Google Scholar
• Sawyer DM, Pace LA, Pascale CL, et al. Lymphocytes influence intracranial aneurysm formation and rupture: role of extracellular matrix remodeling and phenotypic modulation of vascular smooth muscle cells. J Neuroinflammation. 2016;13(1):185. doi:10.1186/s12974-016-0654-z
   PubMed Web of Science ®Google Scholar
• Fan XJ, Zhao HD, Yu G, Zhong XL, Yao H, Yang QD. Role of inflammatory responses in the pathogenesis of human cerebral aneurysm. Genet Mol Res. 2015;14(3):9062–9070. doi:10.4238/2015.August.7.15
   PubMed Web of Science ®Google Scholar
• Arend WP. Interleukin-1 receptor antagonist. Adv Immunol. 1993;54:167–227. doi:10.1016/S0065-2776(08)60535-0
   PubMed Web of Science ®Google Scholar
• Jinfang Z. T helper 2 (Th2) cell differentiation, type 2 innate lymphoid cell (ILC2) development and regulation of interleukin-4 (IL-4) and IL-13 production. Cytokine. 2015;75(1):14–29. doi:10.1016/j.cyto.2015.05.010.T
   PubMed Web of Science ®Google Scholar
• Ye D, Wang Z, Ye J, et al. Interleukin-5 levels are decreased in the plasma of coronary artery disease patients and inhibit Th1 and Th17 differentiation in vitro. Rev Esp Cardiol. 2020;73(5):393–402. doi:10.1016/j.recesp.2019.07.013
   PubMed Web of Science ®Google Scholar
• Zhang H-F, Liang G-B, Zhao M-G, Zhao G-F, Luo Y-H. Regulatory T cells demonstrate significantly increased functions following stimulation with IL-2 in a Tim-3-dependent manner in intracranial aneurysms. Int Immunopharmacol. 2018;65:342–347. doi:10.1016/j.intimp.2018.10.029
   PubMed Web of Science ®Google Scholar
• Read KA, Powell MD, McDonald PW, Oestreich KJ. IL-2, IL-7, and IL-15: multistage regulators of CD4+ T helper cell differentiation. Exp Hematol. 2016;44(9):799–808. doi:10.1016/j.exphem.2016.06.003
   PubMed Web of Science ®Google Scholar
• Boyman O, Sprent J. The role of interleukin-2 during homeostasis and activation of the immune system. Nat Rev Immunol. 2012;12(3):180–190. doi:10.1038/nri3156
   PubMed Web of Science ®Google Scholar